Michael J Sorich (M J Sorich)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Venues

British journal of cancer

Cancers

Biomedicines

JCO precision oncology

Flinders University

University of South Australia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Flinders University Apr 19 2013

Australia

Professor :: Clinical Pharmacology

Education History

University of South Australia

Australia

PHD

Publications

Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 11 (2) (2023)
Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 11 (2) (2023)
Ashley M Hopkins, Michael J Sorich, Andrew J McLachlan, Christos S Karapetis, John O Miners, Madelé van Dyk, Andrew Rowland
Understanding the Risk of Drug Interactions Between Ritonavir-Containing COVID-19 Therapies and Small-Molecule Kinase Inhibitors in Patients With Cancer. JCO precision oncology 7 (2023)
Lee X Li, Federico Cappuzzo, Ignacio Matos, Mark A Socinski, Ashley M Hopkins, Michael J Sorich
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials. The oncologist (2023)
Ashley M Hopkins, Michael J Sorich, Andrew J McLachlan, Christos S Karapetis, John O Miners, Madelé van Dyk, Andrew Rowland
Understanding the Risk of Drug Interactions Between Ritonavir-Containing COVID-19 Therapies and Small-Molecule Kinase Inhibitors in Patients With Cancer. JCO precision oncology 7 (2023)
Jessica M Logan, Ashley M Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R D Johnson, Shane M Hickey, Ben S-Y Ung, Joanna Lazniewska, Robert D Brooks, Courtney R Moore, Maria C Caruso, Litsa Karageorgos, Cara M Martin, Sharon A O'Toole, Laura Bogue Edgerton, Mark P Ward, Mark Bates, Stavros Selemidis, Adrian Esterman, Sheena Heffernan, Helen Keegan, Sarah Ní Mhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Andres Clarke, Nathan Brady, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Michael J Sorich, Kim Moretti, Lisa M Butler, John J O'Leary, Douglas A Brooks
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers 15 (12) (2023)
Jessica M Logan, Ashley M Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R D Johnson, Shane M Hickey, Ben S-Y Ung, Joanna Lazniewska, Robert D Brooks, Courtney R Moore, Maria C Caruso, Litsa Karageorgos, Cara M Martin, Sharon A O'Toole, Laura Bogue Edgerton, Mark P Ward, Mark Bates, Stavros Selemidis, Adrian Esterman, Sheena Heffernan, Helen Keegan, Sarah Ní Mhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Andres Clarke, Nathan Brady, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Michael J Sorich, Kim Moretti, Lisa M Butler, John J O'Leary, Douglas A Brooks
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers 15 (12) (2023)
Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 11 (2) (2023)
Lauren A Newman, Zivile Useckaite, Jillian Johnson, Michael J Sorich, Ashley M Hopkins, Andrew Rowland
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines 10 (1) (2022)
Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, Ahmad Y Abuhelwa, Jessica M Logan, Sarah Badaoui, Christos S Karapetis, Andrew Rowland, Michael J Sorich
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150. British journal of cancer (2021)
Ganessan Kichenadasse, Jim Henry Hughes, Alia Fahmy, Andrew Rowland, Michael J Sorich, Ashley H Hopkins
Relationship Between Apparent Systemic Clearance of Vemurafenib and Toxicity in Patients With Melanoma. Journal of clinical pharmacology 61 (9) (2021)
Jessica M Logan, Douglas A Brooks, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events. Journal of oncology 2021 (2021)
Warit Ruanglertboon, Michael J Sorich, Ashley M Hopkins, Andrew Rowland
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Ahmad Y Abuhelwa, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 13 (5) (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Ahmad Y Abuhelwa, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Reply to Auclin et al. Comment on "Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176". Cancers 13 (15) (2021)
Ashley M Hopkins, Bradley D Menz, Michael D Wiese, Ganessan Kichenadasse, Howard Gurney, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Nuances to precision dosing strategies of targeted cancer medicines. Pharmacology research & perspectives 8 (4) (2021)
Richard John Woodman, Kimberley Bryant, Michael J Sorich, Alberto Pilotto, Arduino Aleksander Mangoni
Use of Multiprognostic Index Domain Scores, Clinical Data, and Machine Learning to Improve 12-Month Mortality Risk Prediction in Older Hospitalized Patients: Prospective Cohort Study. Journal of medical Internet research 23 (6) (2021)
Ahmad Y Abuhelwa, Ganessan Kichenadasse, Ross A McKinnon, Andrew Rowland, Ashley M Hopkins, Michael J Sorich
Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer. Cancers 13 (9) (2021)
Lauren A Newman, Alia Fahmy, Michael J Sorich, Oliver G Best, Andrew Rowland, Zivile Useckaite
Importance of between and within Subject Variability in Extracellular Vesicle Abundance and Cargo when Performing Biomarker Analyses. Cells 10 (3) (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Christos S Karapetis, Andrew Rowland, Michael J Sorich
Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Lauren A Newman, Michael J Sorich, Andrew Rowland
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. Journal of clinical medicine 9 (7) (2020)
Ashley M Hopkins, Jordan Wagner, Ganessan Kichenadasse, Natansh Modi, Andrew Rowland, Michael J Sorich
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy. International journal of cancer 147 (11) (2020)
Ashley M Hopkins, Ganessan Kichenadasse, Elizabeth Garrett-Mayer, Christos S Karapetis, Andrew Rowland, Michael J Sorich
Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Kimberley Bryant, Michael J Sorich, Richard John Woodman, Arduino Aleksander Mangoni
Validation and Adaptation of the Multidimensional Prognostic Index in an Older Australian Cohort. Journal of clinical medicine 8 (11) (2019)
Andrew Rowland, Madelé van Dyk, Ashley M Hopkins, Reham Mounzer, Thomas M Polasek, Amin Rostami-Hodjegan, Michael J Sorich
Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure. Clinical pharmacology and therapeutics 104 (6) (2018)
Ashley M Hopkins, Anh-Minh Nguyen, Christos S Karapetis, Andrew Rowland, Michael J Sorich
Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials. Cancers 10 (10) (2018)

Michael J Sorich.css-eqlu8i{font-size:small;padding-left:4px;} (M J Sorich)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Sorich (M J Sorich)